Dexcom: Innovation and Services as Drivers of Returns - I Expect a Breakout to a New 52-Week High Soon!

Today, Dexcom (DXCM) caught my attention with compelling fundamentals. The company increased its revenue in Q3 by 11% compared to the same period last year and improved the adjusted EPS by nearly 20%. I believe that the topic of diabetes and the associated glucose monitoring is a gigantic market that could hold enormous potential in the future as prosperity grows. With the current launch of the G7 system, which has an extended wear duration of 15 days, DexCom directly addresses user comfort in the U.S. market and strengthens its position against...